Combining multiple microarray studies and modeling interstudy variation

We have established a method for systematic integration of multiple microarray datasets. The method was applied to two different sets of cancer profiling studies. The change of gene expression in cancer was expressed as 'effect size', a standardized index measuring the magnitude of a treatment or covariate effect. The effect sizes were combined to obtain the estimate of the overall mean. The statistical significance was determined by a permutation test extended to multiple datasets. It was shown that the data integration promotes the discovery of small but consistent expression changes with increased sensitivity and reliability. The effect size methods provided the efficient modeling framework for addressing interstudy variation as well. Based on the result of homogeneity tests, a fixed effects model was adopted for one set of datasets that had been created in controlled experimental conditions. By contrast, a random effects model was shown to be appropriate for the other set of datasets that had been published by independent groups. We also developed an alternative modeling procedure based on a Bayesian approach, which would offer flexibility and robustness compared to the classical procedure.

[1]  L. Hedges,et al.  Statistical Methods for Meta-Analysis , 1987 .

[2]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[3]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[4]  W. G. Cochran The combination of estimates from different experiments. , 1954 .

[5]  Jeffrey A. Magee,et al.  Expression profiling reveals hepsin overexpression in prostate cancer. , 2001, Cancer research.

[6]  J. Welsh,et al.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.

[7]  T. Barrette,et al.  Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. , 2002, Cancer research.

[8]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D J Spiegelhalter,et al.  Bayesian approaches to random-effects meta-analysis: a comparative study. , 1995, Statistics in medicine.

[10]  R. Hanka The Handbook of Research Synthesis , 1994 .

[11]  L. Hedges,et al.  The Handbook of Research Synthesis , 1995 .

[12]  S L Normand,et al.  Meta-analysis: formulating, evaluating, combining, and reporting. , 1999, Statistics in medicine.

[13]  M. Bittner,et al.  Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. , 2001, Cancer research.

[14]  Jeffrey E. Harris,et al.  Bayes Methods for Combining the Results of Cancer Studies in Humans and other Species , 1983 .

[15]  Walter R. Gilks,et al.  BUGS - Bayesian inference Using Gibbs Sampling Version 0.50 , 1995 .

[16]  J. Wolfowitz,et al.  An Introduction to the Theory of Statistics , 1951, Nature.

[17]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[18]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[19]  S. Normand,et al.  TUTORIAL IN BIOSTATISTICS META-ANALYSIS : FORMULATING , EVALUATING , COMBINING , AND REPORTING , 1999 .